trevogrumab

Regeneron, Lilly grapple with clinical endpoints as obesity space moves to improving weight loss
Fierce Biotech
Thu, 05/2/24 - 10:14 pm
Regeneron
Eli Lilly
Zepbound
obesity
trevogrumab
bimagrumab